These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
139 related items for PubMed ID: 38801436
1. CD34/S100 protein-positive, NTRK1-rearranged infantile fibrosarcoma-like tumors in genitourinary system: two cases expanding the clinicopathologic spectrum and illustrating the diagnostic dilemma. Zhao M, Xu J, Wang J. Virchows Arch; 2024 Sep; 485(3):575-581. PubMed ID: 38801436 [Abstract] [Full Text] [Related]
2. Clinicopathological findings of pediatric NTRK fusion mesenchymal tumors. Kang J, Park JW, Won JK, Bae JM, Koh J, Yim J, Yun H, Kim SK, Choi JY, Kang HJ, Kim WS, Shin JH, Park SH. Diagn Pathol; 2020 Sep 21; 15(1):114. PubMed ID: 32957984 [Abstract] [Full Text] [Related]
6. Kinase fusion positive intra-osseous spindle cell tumors: A series of eight cases with review of the literature. Suurmeijer AJH, Xu B, Torrence D, Dickson BC, Antonescu CR. Genes Chromosomes Cancer; 2024 Jan 21; 63(1):e23205. PubMed ID: 37782551 [Abstract] [Full Text] [Related]
7. ALK rearrangements in infantile fibrosarcoma-like spindle cell tumours of soft tissue and kidney. Tan SY, Al-Ibraheemi A, Ahrens WA, Oesterheld JE, Fanburg-Smith JC, Liu YJ, Spunt SL, Rudzinski ER, Coffin C, Davis JL. Histopathology; 2022 Mar 21; 80(4):698-707. PubMed ID: 34843129 [Abstract] [Full Text] [Related]
11. Mesenchymal tumors of the gastrointestinal tract with NTRK rearrangements: a clinicopathological, immunophenotypic, and molecular study of eight cases, emphasizing their distinction from gastrointestinal stromal tumor (GIST). Atiq MA, Davis JL, Hornick JL, Dickson BC, Fletcher CDM, Fletcher JA, Folpe AL, Mariño-Enríquez A. Mod Pathol; 2021 Jan 21; 34(1):95-103. PubMed ID: 32669612 [Abstract] [Full Text] [Related]
13. Detection of NTRK fusions in glioblastoma: fluorescent in situ hybridisation is more useful than pan-TRK immunohistochemistry as a screening tool prior to RNA sequencing. Bourhis A, Caumont C, Quintin-Roué I, Magro E, Dissaux G, Remoué A, Le Noac'h P, Douet-Guilbert N, Seizeur R, Tyulyandina A, Schick U, Merlio JP, Marcorelles P, Cappellen D, Uguen A. Pathology; 2022 Feb 21; 54(1):55-62. PubMed ID: 34518039 [Abstract] [Full Text] [Related]
14. A novel group of spindle cell tumors defined by S100 and CD34 co-expression shows recurrent fusions involving RAF1, BRAF, and NTRK1/2 genes. Suurmeijer AJH, Dickson BC, Swanson D, Zhang L, Sung YS, Cotzia P, Fletcher CDM, Antonescu CR. Genes Chromosomes Cancer; 2018 Dec 21; 57(12):611-621. PubMed ID: 30276917 [Abstract] [Full Text] [Related]
15. Pan-Trk Immunohistochemistry Identifies NTRK Rearrangements in Pediatric Mesenchymal Tumors. Rudzinski ER, Lockwood CM, Stohr BA, Vargas SO, Sheridan R, Black JO, Rajaram V, Laetsch TW, Davis JL. Am J Surg Pathol; 2018 Jul 21; 42(7):927-935. PubMed ID: 29683818 [Abstract] [Full Text] [Related]
19. Novel BRAF gene fusions and activating point mutations in spindle cell sarcomas with histologic overlap with infantile fibrosarcoma. Penning AJ, Al-Ibraheemi A, Michal M, Larsen BT, Cho SJ, Lockwood CM, Paulson VA, Liu YJ, Plank L, Fritchie K, Beadling C, Neff TL, Corless CL, Rudzinski ER, Davis JL. Mod Pathol; 2021 Aug 21; 34(8):1530-1540. PubMed ID: 33850302 [Abstract] [Full Text] [Related]